17851196|t|Genetics of Alzheimer's disease. A rapidly evolving field.
17851196|a|Genetic factors have a variable impact on Alzheimer's Disease (AD), ranging from familial forms that are transmitted in an autosomal dominant fashion to sporadic AD, where a polygenic component is present. Most genes conferring susceptibility to AD are related to amyloid-beta deposition (APP; PS1; PS2; APOE; Cystatin-C; ubiquilin-1), oxidative stress (NOS2; NOS3) and inflammatory response (IL-1 alpha; IL-1 beta; IL-6; TNF-alpha). Genome-wide analyses, transcriptomics and proteomics approaches have pointed also to proapoptotic genes as increasing AD liability. Depression and psychotic symptoms that occur in a large proportion of AD patients have been associated with monoamine genes coding for metabolic enzymes (COMT), transporters (5-HTTLPR) and receptors (DRD1; DRD3). Genetic testing may be useful to confirm the diagnosis of AD in individuals with clinical signs of dementia, while it is generally not recommended as a predictive testing for AD in asymptomatic individuals. Drugs currently in use to treat AD are effective in only 20% of patients; their therapeutic effect is predominantly under genetic control (CYP26 gene; APOE). Environmental factors have been shown to moderate the effects of genes on psychiatric disorders such as depression, schizophrenia and ADHD. The study of gene-environment interactions in AD, that are still poorly understood, is essential to predict disease-risk in asymptomatic individuals. Genomics will provide a dynamic picture of biological processes in AD and new targets for the forthcoming anti-AD drugs.
17851196	12	31	Alzheimer's disease	Disease	MESH:D000544
17851196	101	120	Alzheimer's Disease	Disease	MESH:D000544
17851196	122	124	AD	Disease	MESH:D000544
17851196	221	223	AD	Disease	MESH:D000544
17851196	305	307	AD	Disease	MESH:D000544
17851196	323	335	amyloid-beta	Gene	351
17851196	353	356	PS1	Gene	338399
17851196	358	361	PS2	Gene	338412
17851196	363	367	APOE	Gene	348
17851196	369	379	Cystatin-C	Gene	1471
17851196	381	392	ubiquilin-1	Gene	29979
17851196	413	417	NOS2	Gene	4843
17851196	419	423	NOS3	Gene	4846
17851196	429	441	inflammatory	Disease	MESH:D007249
17851196	452	462	IL-1 alpha	Gene	3552
17851196	464	473	IL-1 beta	Gene	3553
17851196	475	479	IL-6	Gene	3569
17851196	481	490	TNF-alpha	Gene	7124
17851196	611	613	AD	Disease	MESH:D000544
17851196	625	635	Depression	Disease	MESH:D003866
17851196	640	658	psychotic symptoms	Disease	MESH:D011618
17851196	695	697	AD	Disease	MESH:D000544
17851196	698	706	patients	Species	9606
17851196	733	742	monoamine	Chemical	-
17851196	800	808	5-HTTLPR	Gene	6532
17851196	825	829	DRD1	Gene	1812
17851196	831	835	DRD3	Gene	1814
17851196	896	898	AD	Disease	MESH:D000544
17851196	937	945	dementia	Disease	MESH:D003704
17851196	1013	1015	AD	Disease	MESH:D000544
17851196	1077	1079	AD	Disease	MESH:D000544
17851196	1109	1117	patients	Species	9606
17851196	1184	1189	CYP26	Gene	1592
17851196	1196	1200	APOE	Gene	348
17851196	1277	1298	psychiatric disorders	Disease	MESH:D001523
17851196	1307	1317	depression	Disease	MESH:D003866
17851196	1319	1332	schizophrenia	Disease	MESH:D012559
17851196	1337	1341	ADHD	Disease	MESH:D001289
17851196	1389	1391	AD	Disease	MESH:D000544
17851196	1560	1562	AD	Disease	MESH:D000544
17851196	1604	1606	AD	Disease	MESH:D000544
17851196	Association	MESH:D011618	1812
17851196	Association	MESH:D011618	6532
17851196	Association	MESH:D000544	348
17851196	Association	MESH:D003866	1814
17851196	Association	MESH:D000544	29979
17851196	Association	MESH:D003866	6532
17851196	Association	MESH:D000544	3552
17851196	Association	MESH:D000544	1592
17851196	Association	MESH:D000544	4846
17851196	Association	MESH:D011618	1814
17851196	Association	MESH:D003866	1812
17851196	Association	MESH:D000544	1471
17851196	Association	338399	351
17851196	Association	338412	351

